Literature DB >> 29878178

Factors Related to Migraine Patients' Decisions to Initiate Behavioral Migraine Treatment Following a Headache Specialist's Recommendation: A Prospective Observational Study.

Mia T Minen1,2, Sarah Azarchi3, Rachel Sobolev3, Amanda Shallcross2, Audrey Halpern1, Thomas Berk1, Naomi M Simon4, Scott Powers5, Richard B Lipton6, Elizabeth Seng6,7.   

Abstract

Objective: To evaluate the frequency with which migraine patients initiated behavioral migraine treatment following a headache specialist recommendation and the predictors for initiating behavioral migraine treatment.
Methods: We conducted a prospective cohort study of consecutive patients diagnosed with migraine to examine whether the patients initiated behavioral migraine treatment following a provider recommendation. The primary outcome was scheduling the initial visit for behavioral migraine treatment. Patients who initiated behavioral migraine treatment were compared with those who did not (demographics, migraine characteristics, and locus of control) with analysis of variance and chi-square tests.
Results: Of the 234 eligible patients, 69 (29.5%) were referred for behavioral treatment. Fifty-three (76.8%) patients referred for behavioral treatment were reached by phone. The mean duration from time of referral to follow-up was 76  (median 76, SD = 45) days. Thirty (56.6%) patients initiated behavioral migraine treatment. There was no difference in initiation of behavioral migraine treatment with regard to sex, age, age of diagnosis, years suffered with headaches, health care utilization visits, Migraine Disability Assessment Screen, and locus of control (P > 0.05). Patients who had previously seen a psychologist for migraine were more likely to initiate behavioral migraine treatment than patients who had not. Time constraints were the most common barrier cited for not initiating behavioral migraine treatment. Conclusions: Less than one-third of eligible patients were referred for behavioral treatment, and only about half initiated behavioral migraine treatment. Future research should further assess patients' decisions regarding behavioral treatment initiation and methods for behavioral treatment delivery to overcome barriers to initiating behavioral migraine treatment.

Entities:  

Mesh:

Year:  2018        PMID: 29878178      PMCID: PMC6454786          DOI: 10.1093/pm/pny028

Source DB:  PubMed          Journal:  Pain Med        ISSN: 1526-2375            Impact factor:   3.750


  37 in total

1.  Psychosocial determinants of mammography follow-up after receipt of abnormal mammography results in medically underserved women.

Authors:  Alecia Malin Fair; Debra Wujcik; Jin-Mann Sally Lin; Wei Zheng; Kathleen M Egan; Ana M Grau; Victoria L Champion; Kenneth A Wallston
Journal:  J Health Care Poor Underserved       Date:  2010-02

Review 2.  Incorporating documents into qualitative nursing research.

Authors:  Fiona A Miller; Kim Alvarado
Journal:  J Nurs Scholarsh       Date:  2005       Impact factor: 3.176

3.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

Review 4.  Behavioral facilitation of medical treatment for headache--part I: Review of headache treatment compliance.

Authors:  Jeanetta C Rains; Gay L Lipchik; Donald B Penzien
Journal:  Headache       Date:  2006-10       Impact factor: 5.887

5.  Engagement in multidisciplinary interventions for pediatric chronic pain: parental expectations, barriers, and child outcomes.

Authors:  Laura E Simons; Deirdre E Logan; Laura Chastain; Madelin Cerullo
Journal:  Clin J Pain       Date:  2010-05       Impact factor: 3.442

Review 6.  Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability.

Authors:  W F Stewart; R B Lipton; A J Dowson; J Sawyer
Journal:  Neurology       Date:  2001       Impact factor: 9.910

7.  Perceived self-efficacy and headache-related disability.

Authors:  D J French; K A Holroyd; C Pinell; P T Malinoski; F O'Donnell; K R Hill
Journal:  Headache       Date:  2000-09       Impact factor: 5.887

8.  Behavioral facilitation of medical treatment of headache: implications of noncompliance and strategies for improving adherence.

Authors:  Jeanetta C Rains; Donald B Penzien; Gay L Lipchik
Journal:  Headache       Date:  2006-10       Impact factor: 5.887

Review 9.  A critical review of the pain readiness to change model.

Authors:  Robert D Kerns; Suzanne Habib
Journal:  J Pain       Date:  2004-09       Impact factor: 5.820

10.  Changes in readiness to self-manage pain are associated with improvement in multidisciplinary pain treatment and pain coping.

Authors:  Mark P Jensen; Warren R Nielson; Judith A Turner; Joan M Romano; Marilyn L Hill
Journal:  Pain       Date:  2004-09       Impact factor: 6.961

View more
  15 in total

1.  A Pilot Randomized Controlled Trial to Assess the Impact of Motivational Interviewing on Initiating Behavioral Therapy for Migraine.

Authors:  Mia T Minen; Gabriella Sahyoun; Ariana Gopal; Valeriya Levitan; Elizabeth Pirraglia; Naomi M Simon; Audrey Halpern
Journal:  Headache       Date:  2020-01-24       Impact factor: 5.887

Review 2.  Mindfulness in migraine: A narrative review.

Authors:  Rebecca Erwin Wells; Elizabeth K Seng; Robert R Edwards; David E Victorson; Charles R Pierce; Lauren Rosenberg; Vitaly Napadow; Zev Schuman-Olivier
Journal:  Expert Rev Neurother       Date:  2020-02-12       Impact factor: 4.618

3.  The use of virtual complementary and integrative therapies by neurology outpatients: An exploratory analysis of two cross-sectional studies assessing the use of technology as treatment in an academic neurology department in New York City.

Authors:  Mia T Minen; Neil A Busis; Steven Friedman; Maya Campbell; Ananya Sahu; Kazi Maisha; Quazi Hossain; Mia Soviero; Deepti Verma; Leslie Yao; Farng-Yang A Foo; Jaydeep M Bhatt; Laura J Balcer; Steven L Galetta; Sujata Thawani
Journal:  Digit Health       Date:  2022-07-17

4.  Behavioral Therapy Preferences in People With Migraine.

Authors:  Mia T Minen; Adama Jalloh; Olivia Begasse de Dhaem; Elizabeth K Seng
Journal:  Headache       Date:  2020-03-23       Impact factor: 5.887

Review 5.  Adherence to Behavioral Therapy for Migraine: Knowledge to Date, Mechanisms for Assessing Adherence, and Methods for Improving Adherence.

Authors:  Alexandra Gewirtz; Mia Minen
Journal:  Curr Pain Headache Rep       Date:  2019-01-19

Review 6.  Efficacy of Biofeedback for Medical Conditions: an Evidence Map.

Authors:  Karli Kondo; Katherine M Noonan; Michele Freeman; Chelsea Ayers; Benjamin J Morasco; Devan Kansagara
Journal:  J Gen Intern Med       Date:  2019-08-14       Impact factor: 5.128

7.  Message Framing and the Willingness to Pursue Behavioral Therapy: A Study of People With Migraine.

Authors:  Adama Jalloh; Olivia Begasse de Dhaem; Elizabeth Seng; Mia T Minen
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2019-08-09       Impact factor: 2.198

8.  Heartrate variability biofeedback for migraine using a smartphone application and sensor: A randomized controlled trial.

Authors:  Mia T Minen; Sarah Corner; Thomas Berk; Valeriya Levitan; Steven Friedman; Samrachana Adhikari; Elizabeth B Seng
Journal:  Gen Hosp Psychiatry       Date:  2021-01-07       Impact factor: 3.238

9.  Smartphone-Delivered Progressive Muscle Relaxation for the Treatment of Migraine in Primary Care: A Randomized Controlled Trial.

Authors:  Mia T Minen; Samrachana Adhikari; Jane Padikkala; Sumaiya Tasneem; Ashley Bagheri; Eric Goldberg; Scott Powers; Richard B Lipton
Journal:  Headache       Date:  2020-11-16       Impact factor: 5.887

10.  Feasibility of Smartphone-Delivered Progressive Muscle Relaxation in Persistent Post-Traumatic Headache Patients.

Authors:  Saima Usmani; Laura Balcer; Steven Galetta; Mia Minen
Journal:  J Neurotrauma       Date:  2020-08-26       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.